Aryl Hydrocarbon Receptor-Dependent Retention of Nuclear HuR Suppresses Cigarette Smoke-Induced Cyclooxygenase-2 Expression Independent of DNA-Binding

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Zago, Michela ^a   Sheridan, Jared A ^a   Nair, Parameswaran ^d   Rico de Souza, Angela ^b   Gallouzi, Imed Eddine ^c   Rousseau, Simon ^a,b   Di Marco, Sergio ^c   Hamid, Qutayba ^a,b   Eidelman, David H ^a,b   Baglole, Carolyn J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CIGARETTE SMOKE; CYCLOOXYGENASE 2; DIOXIN; HUR PROTEIN; MESSENGER RNA; PROSTAGLANDIN; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS CELL; MOUSE; NONHUMAN; NUCLEOTIDE BINDING SITE; PROSTAGLANDIN SYNTHESIS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RNA DEGRADATION; RNA STABILITY; RNA SYNTHESIS; SMOKING;

ANIMALS; AZO COMPOUNDS; CELL NUCLEUS; CELLS, CULTURED; CYCLOOXYGENASE 2; DNA; FIBROBLASTS; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; LUNG; MICE; MODELS, BIOLOGICAL; PROSTAGLANDINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PYRAZOLES; RECEPTORS, ARYL HYDROCARBON; RNA STABILITY; RNA, MESSENGER; RNA, SMALL INTERFERING; SMOKING;

EID: 84884689183     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074953     Document Type: Article

References (89)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757.
2. Barnes PJ, (2000) Chronic obstructive pulmonary disease. N Engl J Med 343: 269-280.
3. Hayashi S, Watanabe J, Nakachi K, Eguchi H, Gotoh O, et al. (1994) Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 15: 801-806.
4. Baglole CJ, Maggirwar SB, Gasiewicz TA, Thatcher TH, Phipps RP, et al. (2008) The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB. J Biol Chem 283: 28944-28957.
5. Thatcher TH, Maggirwar SB, Baglole CJ, Lakatos HF, Gasiewicz TA, et al. (2007) Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. Am J Pathol 170: 855-864.
6. Racky J, Schmitz HJ, Kauffmann HM, Schrenk D, (2004) Single nucleotide polymorphism analysis and functional characterization of the human Ah receptor (AhR) gene promoter. Arch Biochem Biophys 421: 91-98.
7. Rowlands JC, Gustafsson JA, (1997) Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol 27: 109-134.
8. Furness SG, Lees MJ, Whitelaw ML, (2007) The dioxin (aryl hydrocarbon) receptor as a model for adaptive responses of bHLH/PAS transcription factors. FEBS Lett 581: 3616-3625.
9. Nguyen LP, Bradfield CA, (2008) The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 21: 102-116.
10. Vogel CF, Sciullo E, Li W, Wong P, Lazennec G, et al. (2007) RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. Mol Endocrinol 21: 2941-2955.
11. Dong B, Nishimura N, Vogel CF, Tohyama C, Matsumura F, (2010) TCDD-induced cyclooxygenase-2 expression is mediated by the nongenomic pathway in mouse MMDD1 macula densa cells and kidneys. Biochem Pharmacol 79: 487-497.
12. Puga A, Hoffer A, Zhou S, Bohm JM, Leikauf GD, et al. (1997) Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem Pharmacol 54: 1287-1296.
13. Martey CA, Pollock SJ, Turner CK, O'Reilly KM, Baglole CJ, et al. (2004) Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am J Physiol Lung Cell Mol Physiol 287: L981-991.
14. Chen Y, Chen P, Hanaoka M, Droma Y, Kubo K, (2008) Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology 13: 1014-1021.
15. Montuschi P, Kharitonov SA, Ciabattoni G, Barnes PJ, (2003) Exhaled leukotrienes and prostaglandins in COPD. Thorax 58: 585-588.
16. Lofroth G, Rannug A, (1988) Ah receptor ligands in tobacco smoke. Toxicol Lett 42: 131-136.
17. Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T, (1994) Structure of the human cyclo-oxygenase-2 gene. Biochem J 302 (Pt 3): 723-727.
18. Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM, (2000) Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J Biol Chem 275: 11750-11757.
19. Mukhopadhyay D, Houchen CW, Kennedy S, Dieckgraefe BK, Anant S, (2003) Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell 11: 113-126.
20. Sureban SM, Murmu N, Rodriguez P, May R, Maheshwari R, et al. (2007) Functional antagonism between RNA binding proteins HuR and CUGBP2 determines the fate of COX-2 mRNA translation. Gastroenterology 132: 1055-1065.
21. Fan XC, Steitz JA, (1998) Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 17: 3448-3460.
22. Beauchamp P, Nassif C, Hillock S, van der Giessen K, von Roretz C, et al. (2010) The cleavage of HuR interferes with its transportin-2-mediated nuclear import and promotes muscle fiber formation. Cell Death Differ 17: 1588-1599.
23. van der Giessen K, Gallouzi IE, (2007) Involvement of transportin 2-mediated HuR import in muscle cell differentiation. Mol Biol Cell 18: 2619-2629.
24. Rico de Souza A, Zago M, Pollock SJ, Sime PJ, Phipps RP, et al. (2011) Genetic Ablation of the Aryl Hydrocarbon Receptor Causes Cigarette Smoke-induced Mitochondrial Dysfunction and Apoptosis. J Biol Chem 286: 43214-43228.
25. Baglole CJ, Reddy SY, Pollock SJ, Feldon SE, Sime PJ, et al. (2005) Isolation and phenotypic characterization of lung fibroblasts. Methods Mol Med 117: 115-127.
26. Bunger MK, Glover E, Moran SM, Walisser JA, Lahvis GP, et al. (2008) Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor. Toxicol Sci 106: 83-92.
27. Henry EC, Kende AS, Rucci G, Totleben MJ, Willey JJ, et al. (1999) Flavone antagonists bind competitively with 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation. Mol Pharmacol 55: 716-725.
28. Gasiewicz TA, Kende AS, Rucci G, Whitney B, Willey JJ, (1996) Analysis of structural requirements for Ah receptor antagonist activity: ellipticines, flavones, and related compounds. Biochem Pharmacol 52: 1787-1803.
29. Wikenheiser KA, Vorbroker DK, Rice WR, Clark JC, Bachurski CJ, et al. (1993) Production of immortalized distal respiratory epithelial cell lines from surfactant protein C/simian virus 40 large tumor antigen transgenic mice. Proc Natl Acad Sci U S A 90: 11029-11033.
30. Baglole CJ, Bushinsky SM, Garcia TM, Kode A, Rahman I, et al. (2006) Differential induction of apoptosis by cigarette smoke extract in primary human lung fibroblast strains: implications for emphysema. Am J Physiol Lung Cell Mol Physiol 291: L19-29.
31. Baglole CJ, Sime PJ, Phipps RP, (2008) Cigarette smoke-induced expression of heme oxygenase-1 in human lung fibroblasts is regulated by intracellular glutathione. Am J Physiol Lung Cell Mol Physiol 295: L624-636.
32. Carp H, Janoff A, (1978) Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis 118: 617-621.
33. Hyman RW, Davidson N, (1970) Kinetics of the in vitro inhibition of transcription by actinomycin. J Mol Biol 50: 421-438.
34. Denison MS, Nagy SR, (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43: 309-334.
35. Christou M, Savas U, Schroeder S, Shen X, Thompson T, et al. (1995) Cytochromes CYP1A1 and CYP1B1 in the rat mammary gland: cell-specific expression and regulation by polycyclic aromatic hydrocarbons and hormones. Mol Cell Endocrinol 115: 41-50.
36. Eltom SE, Larsen MC, Jefcoate CR, (1998) Expression of CYP1B1 but not CYP1A1 by primary cultured human mammary stromal fibroblasts constitutively and in response to dioxin exposure: role of the Ah receptor. Carcinogenesis 19: 1437-1444.
37. Kim SH, Henry EC, Kim DK, Kim YH, Shin KJ, et al. (2006) Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol Pharmacol 69: 1871-1878.
38. Zhao B, Degroot DE, Hayashi A, He G, Denison MS, (2010) CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor. Toxicol Sci 117: 393-403.
39. Murray IA, Flaveny CA, Chiaro CR, Sharma AK, Tanos RS, et al. (2011) Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3′,4′-dimethoxy-alpha-naphthoflavone. Mol Pharmacol 79: 508-519.
40. Anderson P, Phillips K, Stoecklin G, Kedersha N, (2004) Post-transcriptional regulation of proinflammatory proteins. J Leukoc Biol 76: 42-47.
41. Cok SJ, Acton SJ, Morrison AR, (2003) The proximal region of the 3′-untranslated region of cyclooxygenase-2 is recognized by a multimeric protein complex containing HuR, TIA-1, TIAR, and the heterogeneous nuclear ribonucleoprotein U. J Biol Chem. 278: 36157-36162.
42. Bonelli MA, Alfieri RR, Desenzani S, Petronini PG, Borghetti AF, (2004) Proteasome inhibition increases HuR level, restores heat-inducible HSP72 expression and thermotolerance in WI-38 senescent human fibroblasts. Exp Gerontol 39: 423-432.
43. Poland A, Glover E, Kende AS, (1976) Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J Biol Chem 251: 4936-4946.
44. Okey AB, Franc MA, Moffat ID, Tijet N, Boutros PC, et al. (2005) Toxicological implications of polymorphisms in receptors for xenobiotic chemicals: the case of the aryl hydrocarbon receptor. Toxicol Appl Pharmacol 207: 43-51.
45. Mimura J, Yamashita K, Nakamura K, Morita M, Takagi TN, et al. (1997) Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2: 645-654.
46. Landers JP, Bunce NJ, (1991) The Ah receptor and the mechanism of dioxin toxicity. Biochem J 276 (Pt 2): 273-287.
47. Ema M, Matsushita N, Sogawa K, Ariyama T, Inazawa J, et al. (1994) Human arylhydrocarbon receptor: functional expression and chromosomal assignment to 7p21. J Biochem 116: 845-851.
48. Fernandez-Salguero PM, Ward JM, Sundberg JP, Gonzalez FJ, (1997) Lesions of aryl-hydrocarbon receptor-deficient mice. Vet Pathol 34: 605-614.
49. Schmidt JV, Su GH, Reddy JK, Simon MC, Bradfield CA, (1996) Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci U S A 93: 6731-6736.
50. Ohtake F, Baba A, Takada I, Okada M, Iwasaki K, et al. (2007) Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 446: 562-566.
51. Patel RD, Murray IA, Flaveny CA, Kusnadi A, Perdew GH, (2009) Ah receptor represses acute-phase response gene expression without binding to its cognate response element. Lab Invest 89: 695-707.
52. Murray IA, Krishnegowda G, DiNatale BC, Flaveny C, Chiaro C, et al. (2010) Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties. Chem Res Toxicol 23: 955-966.
53. Song J, Clagett-Dame M, Peterson RE, Hahn ME, Westler WM, et al. (2002) A ligand for the aryl hydrocarbon receptor isolated from lung. Proc Natl Acad Sci U S A 99: 14694-14699.
54. Quintana FJ, Murugaiyan G, Farez MF, Mitsdoerffer M, Tukpah AM, et al. (2010) An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 107: 20768-20773.
55. Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, et al. (2008) Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453: 65-71.
56. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, et al. (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453: 106-109.
57. Henry EC, Welle SL, Gasiewicz TA, (2010) TCDD and a putative endogenous AhR ligand, ITE, elicit the same immediate changes in gene expression in mouse lung fibroblasts. Toxicol Sci 114: 90-100.
58. Henry EC, Bemis JC, Henry O, Kende AS, Gasiewicz TA, (2006) A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo. Arch Biochem Biophys 450: 67-77.
59. Denison MS, Soshilov AA, He G, DeGroot DE, Zhao B, (2011) Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci 124: 1-22.
60. Hestermann EV, Brown M, (2003) Agonist and chemopreventative ligands induce differential transcriptional cofactor recruitment by aryl hydrocarbon receptor. Mol Cell Biol 23: 7920-7925.
61. Guyot E, Chevallier A, Barouki R, Coumoul X (2012) The AhR twist: ligand-dependent AhR signaling and pharmaco-toxicological implications. Drug Discov Today.
62. Anderson P, (2008) Post-transcriptional control of cytokine production. Nat Immunol 9: 353-359.
63. Clark A, (2000) Post-transcriptional regulation of pro-inflammatory gene expression. Arthritis Res 2: 172-174.
64. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, et al. (1986) Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A 83: 1670-1674.
65. Hel Z, Di Marco S, Radzioch D, (1998) Characterization of the RNA binding proteins forming complexes with a novel putative regulatory region in the 3′-UTR of TNF-alpha mRNA. Nucleic Acids Res 26: 2803-2812.
66. Sobell HM, (1985) Actinomycin and DNA transcription. Proc Natl Acad Sci U S A 82: 5328-5331.
67. von Roretz C, Di Marco S, Mazroui R, Gallouzi IE, (2011) Turnover of AU-rich-containing mRNAs during stress: a matter of survival. Wiley Interdiscip Rev RNA 2: 336-347.
68. Sengupta S, Jang BC, Wu MT, Paik JH, Furneaux H, et al. (2003) The RNA-binding protein HuR regulates the expression of cyclooxygenase-2. J Biol Chem 278: 25227-25233.
69. Natarajan G, Ramalingam S, Ramachandran I, May R, Queimado L, et al. (2008) CUGBP2 downregulation by prostaglandin E2 protects colon cancer cells from radiation-induced mitotic catastrophe. Am J Physiol Gastrointest Liver Physiol 294: G1235-1244.
70. Cha HJ, Lee HH, Chae SW, Cho WJ, Kim YM, et al. (2011) Tristetraprolin downregulates the expression of both VEGF and COX-2 in human colon cancer. Hepatogastroenterology 58: 790-795.
71. Lin WN, Lin CC, Cheng HY, Yang CM, (2011) Regulation of cyclooxygenase-2 and cytosolic phospholipase A2 gene expression by lipopolysaccharide through the RNA-binding protein HuR: involvement of NADPH oxidase, reactive oxygen species and mitogen-activated protein kinases. Br J Pharmacol 163: 1691-1706.
72. Jeyaraj SC, Dakhlallah D, Hill SR, Lee BS, (2006) Expression and distribution of HuR during ATP depletion and recovery in proximal tubule cells. Am J Physiol Renal Physiol 291: F1255-1263.
73. Abdelmohsen K, Srikantan S, Yang X, Lal A, Kim HH, et al. (2009) Ubiquitin-mediated proteolysis of HuR by heat shock. EMBO J 28: 1271-1282.
74. Fan J, Ishmael FT, Fang X, Myers A, Cheadle C, et al. (2011) Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium. J Immunol 186: 2482-2494.
75. Atasoy U, Watson J, Patel D, Keene JD, (1998) ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J Cell Sci 111 (Pt 21): 3145-3156.
76. Nowotarski SL, Shantz LM, (2010) Cytoplasmic accumulation of the RNA-binding protein HuR stabilizes the ornithine decarboxylase transcript in a murine nonmelanoma skin cancer model. J Biol Chem 285: 31885-31894.
77. Lebedeva S, Jens M, Theil K, Schwanhausser B, Selbach M, et al. (2011) Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol Cell 43: 340-352.
78. Meisner NC, Filipowicz W, (2010) Properties of the regulatory RNA-binding protein HuR and its role in controlling miRNA repression. Adv Exp Med Biol 700: 106-123.
79. Marlowe JL, Fan Y, Chang X, Peng L, Knudsen ES, et al. (2008) The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Mol Biol Cell 19: 3263-3271.
80. Chang X, Fan Y, Karyala S, Schwemberger S, Tomlinson CR, et al. (2007) Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor. Mol Cell Biol 27: 6127-6139.
81. Blaxall BC, Dwyer-Nield LD, Bauer AK, Bohlmeyer TJ, Malkinson AM, et al. (2000) Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol Carcinog 28: 76-83.
82. Sgantzis N, Yiakouvaki A, Remboutsika E, Kontoyiannis DL, (2011) HuR controls lung branching morphogenesis and mesenchymal FGF networks. Dev Biol 354: 267-279.
83. Roemer E, Stabbert R, Rustemeier K, Veltel DJ, Meisgen TJ, et al. (2004) Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 195: 31-52.
84. Rustemeier K, Stabbert R, Haussmann HJ, Roemer E, Carmines EL, (2002) Evaluation of the potential effects of ingredients added to cigarettes. Part 2: chemical composition of mainstream smoke. Food Chem Toxicol 40: 93-104.
85. Church DF, Pryor WA, (1985) Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64: 111-126.
86. Cheng YH, Huang SC, Lin CJ, Cheng LC, Li LA, (2012) Aryl hydrocarbon receptor protects lung adenocarcinoma cells against cigarette sidestream smoke particulates-induced oxidative stress. Toxicol Appl Pharmacol 259: 293-301.
87. Ikuta T, Kobayashi Y, Kawajiri K, (2004) Cell density regulates intracellular localization of aryl hydrocarbon receptor. J Biol Chem 279: 19209-19216.
88. Cho YC, Zheng W, Jefcoate CR, (2004) Disruption of cell-cell contact maximally but transiently activates AhR-mediated transcription in 10T1/2 fibroblasts. Toxicol Appl Pharmacol 199: 220-238.
89. Safe S, Qin C, McDougal A, (1999) Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer. Expert Opin Investig Drugs 8: 1385-1396.